HBIO harvardbioscience.com: Expected earnings per share growth for next year
Deep robotization of precision instrument assembly at Harvard Bioscience (HBIO) minimizes costs, which is evident when viewing the chart on GURU.Markets: consensus expectations for n+1 profit dynamics demonstrate market demand, where 97.80 characterizes this valuation parameter. Its gold standard status in science makes the equipment indispensable for pharmaceutical laboratories, while a focus on direct sales and asset integration optimizes margins.
Analytical breakdowns for Harvard Bioscience
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
Debt to Equity Harvard Bioscience|HBIO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Harvard Bioscience, Inc.|HBIO - Company Cumulative Debt|Debt to Book Capitalization Ratio Harvard Bioscience|HBIO - Company Long-Term Indebtedness|Company Current Liabilities Harvard Bioscience|Quick Liquidity harvardbioscience.com
- net income and valuation ratios data:
HBIO - Net Financial Result|Projected Future Earnings Harvard Bioscience|HBIO - Company Value to Net Income|Forward P/E Multiple Harvard Bioscience|HBIO - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Harvard Bioscience|HBIO - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Harvard Bioscience|HBIO - Earnings per share for the last twelve months|Quarterly EPS earnings growth harvardbioscience.com|HBIO - Earnings growth in current year|Net earnings per share growth forecast for next year Harvard Bioscience
Fundamental company analysis:HBIO, Harvard Bioscience
Conservative capital demands maximum transparency in assessing future cash flows and earnings sustainability. This indicator tracks the trend of the consensus forecast for earnings per share growth rates, signaling valuation revisions by investment houses and the risk of overpayment at extreme values. For Harvard Bioscience (HBIO), this is critical, as the expected EPS change for the coming year reflects the effectiveness of cost optimization amid a cyclical capex downturn in the laboratory sector.
Competing companies
Net earnings per share growth forecast for next year Intuitive Surgical Inc|Danaher Corporation Inc. (DHR) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year BDX (Becton Dickinson & Co)|Projected earnings per share increase next year STE|Net earnings per share growth forecast for next year West Pharmaceutical Services, Inc. WST|Expected earnings per share trend next year BAX|MASI: Expected earnings per share growth for next year|STVN - Earnings growth forecast for next year|Teleflex Incorporated (TFX) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year merit.com|NVST (Envista) - Earnings growth forecast for next year|Expected net earnings per share growth next year ICU Medical Inc ICUI|Net earnings per share growth forecast for next year Dentsply (XRAY)|LeMaitre Corp - Projected earnings per share growth rate for next year|AtriCure, Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year STAA (staar.com)|NAGE - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year ZimVie Inc ZIMV|ANGO: Earnings growth forecast for next year|Cerus Inc - Expected earnings per share trend next year|TKNO (Alpha Teknova, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year monogramorthopedics.com|Net earnings per share growth forecast for next year Sharps Technology, Inc. (STSS)|INFU (infusystem.com) - Expected earnings per share trend next year|Utah Medical - Expected earnings per share growth for next year|KORU Medical Systems, Inc. - Net earnings per share growth forecast for next year|Nyxoah S.A. - Earnings growth forecast for next year|MBOT - Earnings growth forecast for next year|Pro-Dex (PDEX) - Net earnings per share growth forecast for next year|Zentek Ltd - Expected earnings per share trend next year|ELUT (Elutia Corp) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year MLSS (Milestone Scientific Corporation)|Expected earnings per share growth for next year NXGL (NEXGEL, Inc.)|RVP (retractable.com) - Expected earnings per share trend next year|Earnings growth forecast for next year FEMY (Femasys)|Meihua Medical Technologies - Net earnings per share growth forecast for next year|Predictive Oncology Corp - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Callan JMB Inc CJMB|Atrion Corporation (ATRI) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year neurometrix.com (NURO)
